TuisPEB • NZE
add
Pacific Edge Ltd
Vorige sluiting
$0,14
Dagwisseling
$0,14 - $0,14
Jaarwisseling
$0,071 - $0,19
Markkapitalisasie
113,67 m NZD
Gemiddelde volume
192,85 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NZE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (NZD) | Mrt. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 5,64 m | -2,51% |
Bedryfskoste | 10,69 m | -11,05% |
Netto inkomste | -7,14 m | 12,88% |
Netto winsgrens | -126,68 | 10,64% |
Wins per aandeel | — | — |
EBITDA | -7,75 m | 9,33% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (NZD) | Mrt. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 50,26 m | -35,39% |
Totale bates | 65,45 m | -28,01% |
Totale aanspreeklikheid | 10,83 m | 32,83% |
Totale ekwiteit | 54,62 m | — |
Uitstaande aandele | 811,27 m | — |
Prys om te bespreek | 2,03 | — |
Opbrengs op bates | -30,03% | — |
Opbrengs op kapitaal | -33,48% | — |
Kontantvloei
Netto kontantverandering
| (NZD) | Mrt. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -7,14 m | 12,88% |
Kontant van bedrywe | -5,38 m | 7,28% |
Kontant van beleggings | 10,06 m | 123,79% |
Kontant van finansiering | -199,50 k | 59,90% |
Netto kontantverandering | 4,40 m | 284,71% |
Beskikbare kontantvloei | -4,15 m | 22,62% |
Meer oor
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the New Zealand NZX main board stock exchange and is included in the NZX 50 Index. Wikipedia
Gestig
2001
Webwerf
Werknemers
114
